- Home
- PEPG vs IMRX Comparison
PEPG vs IMRX Comparison
Compare PEPG & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- IMRX
- Stock Information
- Founded
- PEPG 2018
- IMRX 2008
- Country
- PEPG United States
- IMRX United States
- Employees
- PEPG N/A
- IMRX N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- PEPG Health Care
- IMRX Health Care
- Exchange
- PEPG Nasdaq
- IMRX Nasdaq
- Market Cap
- PEPG 52.4M
- IMRX 52.2M
- IPO Year
- PEPG 2022
- IMRX 2021
- Fundamental
- Price
- PEPG $1.42
- IMRX $2.05
- Analyst Decision
- PEPG Buy
- IMRX Strong Buy
- Analyst Count
- PEPG 3
- IMRX 3
- Target Price
- PEPG $7.67
- IMRX $14.33
- AVG Volume (30 Days)
- PEPG 216.6K
- IMRX 265.4K
- Earning Date
- PEPG 05-08-2025
- IMRX 08-05-2025
- Dividend Yield
- PEPG N/A
- IMRX N/A
- EPS Growth
- PEPG N/A
- IMRX N/A
- EPS
- PEPG N/A
- IMRX N/A
- Revenue
- PEPG N/A
- IMRX N/A
- Revenue This Year
- PEPG N/A
- IMRX N/A
- Revenue Next Year
- PEPG N/A
- IMRX N/A
- P/E Ratio
- PEPG N/A
- IMRX N/A
- Revenue Growth
- PEPG N/A
- IMRX N/A
- 52 Week Low
- PEPG $0.88
- IMRX $1.00
- 52 Week High
- PEPG $19.30
- IMRX $3.83
- Technical
- Relative Strength Index (RSI)
- PEPG 46.62
- IMRX 73.63
- Support Level
- PEPG $1.35
- IMRX $1.58
- Resistance Level
- PEPG $1.55
- IMRX $2.02
- Average True Range (ATR)
- PEPG 0.15
- IMRX 0.17
- MACD
- PEPG -0.00
- IMRX 0.06
- Stochastic Oscillator
- PEPG 18.42
- IMRX 98.06
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.